Citadel Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-30,376
| Closed | -$15.3K | – | 11806 |
|
|
2020
Q3 | $16K | Buy |
+30,376
| New | +$21.8K | ﹤0.01% | 9902 |
|
|
2020
Q2 | – | Sell |
-81,333
| Closed | -$69K | – | 10816 |
|
|
2020
Q1 | $69K | Buy |
81,333
+33,645
| +71% | +$48.1K | ﹤0.01% | 8865 |
|
|
2019
Q4 | $78K | Buy |
47,688
+30,254
| +174% | +$45.4K | ﹤0.01% | 8641 |
|
|
2019
Q3 | $19K | Buy |
17,434
+5,026
| +41% | +$5.81K | ﹤0.01% | 8954 |
|
|
2019
Q2 | $15K | Buy |
+12,408
| New | +$15.8K | ﹤0.01% | 8986 |
|
|
2019
Q1 | – | Sell |
-59,813
| Closed | -$71K | – | 10141 |
|
|
2018
Q4 | $71K | Buy |
59,813
+16,387
| +38% | +$24.3K | ﹤0.01% | 8391 |
|
|
2018
Q3 | $59K | Sell |
43,426
-8,956
| -17% | -$14.2K | ﹤0.01% | 8772 |
|
|
2018
Q2 | $120K | Buy |
+52,382
| New | +$101K | ﹤0.01% | 8164 |
|
|
2018
Q1 | – | Sell |
-26,805
| Closed | -$20K | – | 9011 |
|
|
2017
Q4 | $20K | Sell |
26,805
-13,325
| -33% | -$11.9K | ﹤0.01% | 7831 |
|
|
2017
Q3 | $47K | Sell |
40,130
-44,913
| -53% | -$56.6K | ﹤0.01% | 7197 |
|
|
2017
Q2 | $148K | Sell |
85,043
-115,670
| -58% | -$246K | ﹤0.01% | 6750 |
|
|
2017
Q1 | $530K | Buy |
200,713
+170,036
| +554% | +$611K | ﹤0.01% | 4920 |
|
|
2016
Q4 | $130K | Sell |
30,677
-60,446
| -66% | -$199K | ﹤0.01% | 6573 |
|
|
2016
Q3 | $243K | Buy |
+91,123
| New | +$210K | ﹤0.01% | 6020 |
|
|
2016
Q2 | – | Sell |
-11,775
| Closed | -$27K | – | 7639 |
|
|
2016
Q1 | $27K | Sell |
11,775
-33,769
| -74% | -$76.4K | ﹤0.01% | 6400 |
|
|
2015
Q4 | $158K | Buy |
+45,544
| New | +$218K | ﹤0.01% | 6140 |
|
|
2015
Q3 | – | Sell |
-178,581
| Closed | -$1.18M | – | 9389 |
|
|
2015
Q2 | $1.18M | Buy |
178,581
+68,221
| +62% | +$460K | ﹤0.01% | 3750 |
|
|
2015
Q1 | $786K | Buy |
+110,360
| New | +$832K | ﹤0.01% | 4264 |
|
Other funds holding GEN
IC
TRCT
Citadel Advisors's GEN Position: Q4 2020 in Review
Citadel Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q4 2020, closing a stake of 30,376 shares — an estimated $15.3K sold.
Citadel Advisors first reported a position in GEN in Q1 2015 and held it in 18 quarters. The position peaked at $1.18M in Q2 2015. 49 funds tracked by Wall St. Rank hold GEN as of Q4 2020.
- Citadel Advisors reported no remaining Genesis Healthcare, Inc. position as of Q4 2020 after selling out during the quarter.
- Citadel Advisors sold 30,376 Genesis Healthcare, Inc. shares in Q4 2020, an estimated $15.3K.
- Citadel Advisors first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 18 quarters.
- Citadel Advisors's Genesis Healthcare, Inc. position peaked at $1.18M in Q2 2015.
- 49 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2020.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.